Evaluation and treatment of dyspepsia

Postgraduate Medical Journal

Volumn 79, Issue 927, 2003, Pages 25-29

  Jones, Michael P ^a,b  

^a Galter Pavilion 4 104 ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; CANCER; CONSULTATION; DISEASE SEVERITY; DYSPEPSIA; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC DISEASE; PEPTIC ULCER; PSYCHOTHERAPY; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING;

ADULT; DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PEPTIC ULCER;

EID: 0037286298     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.927.25     Document Type: Review

References (46)

1. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999;45(suppl 2):II37-42.
2. Jones R. Dyspeptic symptoms in the community. Gut 1989;30:893-8.
3. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102(4 pt 1):1259-68.
4. Brown C, Rees WD. Dyspepsia in general practice. BMJ 1990;300:829-30.
5. Tebaldi M, Heading RC. Clinical economics review: functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther 1998;12:11-9.
6. Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut 2002;50(suppl 4):iv10-2.
7. Fennerty MB. Use of antisecretory agents as a trial of therapy. Gut 2002;50(suppl 4):iv63-6.
8. Nyren O, Adami HO, Gustavsson S, et al. Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol Suppl 1985;109:41-7.
9. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995;40:584-9.
10. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
11. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB, et al. Predicting endascopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol 1997;32:118-25.
12. Fisher RS, Parkman HP. Management of nonulcer dyspepsia. N Engl J Med 1998;339:1376-81.
13. American Gastroenterological Association. Medical position statement: evaluation of dyspepsia. Gastroenterolagy 1998;114:579-81.
14. Talley NJ, Silverstein MD, Agreus L, et al. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998;114:582-95.
15. Mason I, Millar LJ, Sheikh RR, et al. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group. Aliment Pharmacol Ther 1998;12:263-71.
16. Jones RH, Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg bd in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997;11:541-6.
17. Meineche-Schmidt V, Krag E. Antisecretory therapy in 1017 patients with ulcerlike or refluxlike dyspepsia in general practice. Eur J Gen Pract 1997;3:125-30.
18. Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992;51(suppl 1):59-67.
19. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002;50(suppl 4):iv72-8.
20. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
21. Talley NJ, Axon A, Bytzer P, et al. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther 1999;13:1135-48.
22. Cutler AF, Havstad S, Ma CK, et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.
23. Greenberg RE, Bonk S. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age. Arch Intern Med 1990;150:2053-5.
24. Bruno J, Jones M. No Hp-no PUD. The importance of determining community prevalence rates of Helicobacter pylori in formulating clinical pathways for the evaluation of dyspepsia. Am J Gastroenterol 1997;92:A1610.
25. Faigel DO, Childs M, Furth EE, et al. New noninvasive tests for Helicobacter pylori gastritis. Comparison with tissue-based gold standard. Dig Dis Sci 1996;41:740-8.
26. Kenney G, Paladino M, Davis B. The prevalence of Helicobacter pylori is low in rural northwestern Pennsylvania. Am J Gastroenterol 1997;92:A1617.
27. Talley NJ, Vakil N, Ballard ED, et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999;341:1106-11.
28. Blum AL, Talley NJ, O'Morain C, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998;339:1875-81.
29. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-65.
30. Lauritsen K, Aaylkke C, Havelund T, et al. Effect of omeprazole in functional dyspepsia: a double-blind, randomized, placebo-controlled study. Gastroenterology 1996;110(suppl):A702.
31. Soykan I, Lin Z, Jones S, et al. Gastric myoelectrical activity, gastric emptying and correlations with dyspepsia symptoms in patients with gastroesophageal reflux. J Invest Med 1997;45:483-7.
32. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
33. Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985;88(5 pt 1):1223-31.
34. Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-52.
35. Tack J, Coulie B, Wilmer A, et al. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000;46:468-73.
36. Coulie B, Tack J, Janssens J. Influence of buspirone-induced fundus relaxation on the perception of gastric distention in man. Gastroenterology 1997;112:A715.
37. Tack J, Caenepeel P, Fischler B, et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001;121:526-35.
38. Holtmann G, Gschossmann J, Neufang-Huber J, et al. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut 2000;47:332-6.
39. Salet GA, Samsom M, Roelofs JM, et al. Responses to gastric distension in functional dyspepsia. Gut 1998;42:823-9.
40. Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998;115:1263-71.
41. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-8.
42. Langeluddecke P, Goulston K, Tennant C. Psychological factors in dyspepsia of unknown cause: a comparison with peptic ulcer disease. J Psychosom Res 1990;34:215-22.
43. Talley NJ, Fung LH, Gilligan U, et al. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology 1986;90:886-92.
44. Talley NJ, Fett SL, Zinsmeister AR, et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994;107:1040-9.
45. Dobrilla G, Comberlato M, Steele A, et al. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989;11:169-77.
46. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660-73.